Login
Home / PULM : NASDAQ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Pulmatrix, Inc.

$1.46 -$0.80 (-35.40%)
NASDAQ · 14 Sep 2026 16:25 UTC
Previous Close
$1.41
Day Range
$1.39$1.47
Year Range
$1.16$5.5
Market Cap
5.33M
AVG Volume
41.46K
Trailing/Forward PE
-1.33/2.52
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (USD) · TTM
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (USD) · TTM
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (USD) · TTM
-10M-7.5M-5M-2.5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (USD) · TTM
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (USD) · TTM
-4-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (USD) · TTM
010M20M30MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding (USD) · TTM
-1M-750K-500K-250K0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Employee Count
01020302016201720182019202020212022202320242025
Free Cash Flow Yield
-200%-150%-100%-50%0%med -53.25%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
02000400060008000med 2.86May 24Sep 24Dec 24Apr 25Jul 25Nov 25Feb 26
Price/Operating Cashflow
246810med 5.39Aug 19Oct 19Dec 19Feb 20Apr 20Jun 20Jul 20
Price to Book
0246med 2.2Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Pulmatrix, Inc.
PULM
Stockpicker

Video analysis: PULM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PULM

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

prnewswire.com · 13 Aug 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

Form S-4 filed related to the announced merger agreement with Eos SENOLYTIX FRAMINGHAM, Mass., Aug. 13, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented iSPERSE™ technology, today announced its second quarter financial results for 2026 and provided a corporate update related to the merger agreement with Eos SENOLYTIX announced at the end of the first quarter of 2026.
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN

gurufocus.com · 10 Jul 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN

SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN PR Newswire

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.